This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Parvovirus Type 2 Capsid Protein (VP2), His
Product Overview
BioVenic's Recombinant Canine Parvovirus Type 2 Capsid Protein (VP2), His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 64.6 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The canine parvovirus type 2 capsid protein (VP2) is a major structural protein of CPV-2, constituting 90% of the viral capsid. In veterinary medicine, VP2 acts as the main protective antigen, inducing neutralizing antibodies that provide immune protection. It also determines the host range, tissue tropism, and antigenicity of the virus. VP2 mediates viral entry into host cells by binding to the transferrin receptor (TfR) on canine cells. In diagnostics, VP2 is widely used to develop diagnostic tools such as ELISA kits for detecting CPV-2 infections. Additionally, VP2 is a key target for vaccine development, with VP2-based vaccines showing good immune protection against CPV-2 infections.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.